More BCAL Diagnostics Limited news
BCAL Diagnostics LimitedASX: BDX

Appendix 4E and Annual Report to Shareholders

Aug 30, 2024 at 7:48 AM EDT · Issued by BCAL Diagnostics Limited

Filed with ASX · Aug 30, 2024 at 7:48 AM EDT

On 6ix: 6ix.com/news/appendix-4e-and-annual-report-to-shareholders-24

Bcal Diagnostics Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

BCAL Diagnostics Limited on 6ix

Story so far

  • Appendix 4D & Interim ReportFeb 18, 2022

Earlier from BCAL Diagnostics

  • BCAL Commences US OperationsAug 28, 2024
  • BCAL Receives Firm Commitments to Raise $10.5 MillionJun 3, 2024
  • Reinstatement to QuotationJun 3, 2024
  • Suspension from QuotationMay 30, 2024
  • Response to ASX Price QueryMay 30, 2024

Later from BCAL Diagnostics

  • BCAL Diagnostics Receives NATA AccreditationDec 11, 2024
  • NATA Accreditation ClarificationDec 12, 2024
  • BCAL Launches Breastest Plus Generating First RevenuesMar 23, 2025
  • Investor PresentationMar 24, 2025
  • Commercial Partnership with Cancer Care AssociatesJul 2, 2025
All BCAL Diagnostics news releases↗

Follow BCAL Diagnostics into a list and get an email when it puts out news.

Follow BCAL Diagnostics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer